Suchergebnisse
Katalog
Mehr
Suchmaske
Suchergebnisse einschränken oder erweitern
Aktive Suchfilter
Weniger Treffer
Art der Quelle
Thema
- pharmaceutical industry 9 Treffer
- drug development 6 Treffer
- business cycles 4 Treffer
- business finance 4 Treffer
- corporate growth 4 Treffer
-
45 weitere Werte:
- corporate profits 4 Treffer
- financial performance 4 Treffer
- h. lundbeck a/s 4 Treffer
- industrial location 4 Treffer
- drug approval 3 Treffer
- drug marketing 3 Treffer
- united states. food & drug administration 3 Treffer
- clinical trials 2 Treffer
- forest laboratories inc. 2 Treffer
- sun pharmaceutical industries ltd. 2 Treffer
- actavis sarl (1958-2012) 1 Treffer
- allergan inc. (1948-2015) 1 Treffer
- antidepressants 1 Treffer
- anxiety disorders treatment 1 Treffer
- bausch health cos. inc. 1 Treffer
- baxter international inc. 1 Treffer
- biogen inc. (2003- ) 1 Treffer
- biovail corp. 1 Treffer
- boehringer ingelheim gmbh 1 Treffer
- bristol-myers squibb co. 1 Treffer
- central nervous system depressants 1 Treffer
- depomed inc. 1 Treffer
- epidemiology 1 Treffer
- etiology of diseases 1 Treffer
- gastrointestinal disease treatment 1 Treffer
- genetics 1 Treffer
- glaxosmithkline 1 Treffer
- human genetics 1 Treffer
- insomnia 1 Treffer
- jazz pharmaceuticals inc. 1 Treffer
- medical research 1 Treffer
- mental depression 1 Treffer
- multiple sclerosis treatment 1 Treffer
- neurodegeneration 1 Treffer
- novartis ag 1 Treffer
- pfizer inc. 1 Treffer
- pharmaceutical industry mergers 1 Treffer
- pharmaceutical policy 1 Treffer
- postoperative pain treatment 1 Treffer
- revenue 1 Treffer
- sales 1 Treffer
- sepracor inc. 1 Treffer
- shire pharmaceuticals group plc 1 Treffer
- sumitomo dainippon pharma co. ltd. 1 Treffer
- sun pharmaceuticals llc 1 Treffer
Verlag
Publikation
Sprache
Inhaltsanbieter
16 Treffer
-
In: Shire Pharmaceuticals Group, PLC SWOT Analysis, 2007-08-01, S. 4-4unknownZugriff:
-
In: PharmaWatch: Monthly Review, Jg. 9 (2010-04-01), Heft 4, S. 11-12reportZugriff:
-
In: H. Lundbeck A/S SWOT Analysis, 2006-05-01, S. 4-4unknownZugriff:
-
In: H. Lundbeck A/S SWOT Analysis, 2006-05-01, S. 4-4unknownZugriff:
-
In: H. Lundbeck A/S SWOT Analysis, 2006-05-01, S. 1-8unknownZugriff:
-
In: PharmaWatch: CNS, Jg. 3 (2004-11-01), Heft 11, S. 17-23reportZugriff:
-
In: PharmaWatch: Monthly Review, Jg. 9 (2010-08-01), Heft 8, S. 8-9reportZugriff:
-
In: PharmaWatch: Monthly Review, Jg. 9 (2010-06-01), Heft 6, S. 9-10reportZugriff:
-
In: PharmaWatch: Monthly Review, Jg. 9 (2010-05-01), Heft 5, S. 14-15reportZugriff:
-
In: PharmaWatch: Monthly Review, Jg. 8 (2009-12-01), Heft 12, S. 11-12reportZugriff:
-
In: PharmaWatch: Monthly Review, Jg. 8 (2009-10-01), Heft 10, S. 12-13reportZugriff:
-
In: PharmaWatch: Monthly Review, Jg. 7 (2008-06-01), Heft 6, S. 12-13reportZugriff:
-
In: PharmaWatch: Monthly Review, Jg. 7 (2008), Heft 1, S. 16-17reportZugriff:
-
In: PharmaWatch: CNS, Jg. 3 (2004-12-01), Heft 12, S. 2-3reportZugriff:
-
In: European Journal of Haematology, Jg. 72 (2004), Heft 1, S. 67-70Online reviewZugriff:
-
In: PharmaWatch: CNS, Jg. 3 (2004-11-01), Heft 11, S. 24-24reportZugriff: